Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

ParaDefense™ and Jill Rappaport Team Up to Protect the Neediest of Pets; New ParaDefense Increases Shelters Accessibility and Affordability of Flea Protection
  • USA - English


News provided by

CapInnoVet

Feb 24, 2016, 09:30 ET

Share this article

Share toX

Share this article

Share toX

Jill Rappaport joined the ParaDefense campaign to raise awareness of the need for preventative healthcare for all pets and to encourage pet lovers across the country to support disadvantaged pets.
Jill Rappaport joined the ParaDefense campaign to raise awareness of the need for preventative healthcare for all pets and to encourage pet lovers across the country to support disadvantaged pets.
Youtube
Youtube

New York, NY (PRWEB) February 24, 2016 -- Jill Rappaport, award-winning animal advocate, journalist and best-selling author, has joined CapInnoVet to introduce ParaDefense, the first generic imidacloprid/pyriproxyfen product available through shelters and veterinary clinics nationwide with the same active ingredients as Advantage® II*. To celebrate the launch, Jill Rappaport is working with ParaDefense on a national awareness campaign highlighting the importance of flea treatment and preventative pet healthcare for the neediest of pets, those just rescued.

I take great comfort in knowing that all the shelter dogs and cats will now have the opportunity to be protected thanks to ParaDefense.

Post this

ParaDefense kicked off the campaign at Southampton Animal Shelter last week by donating the first of 1,000 doses of monthly flea treatment to protect dogs and cats recently rescued and soon to be up for adoption. The first pets who received ParaDefense were those just rescued as part of Animal Lighthouse Rescue arranged by Kate McEntee, Director at Southampton Animal Shelter. “Ten dogs arrived safely from Puerto Rico just this weekend. They are doing great and thanks to ParaDefense they are now protected from fleas and will soon be ready for adoption," says Dr. Teri Meekins, staff Veterinarian at Southampton Animal Shelter Foundation. “It is critical that shelters like ours have access to lower cost, high quality medications." The donated ParaDefense will be used on all the shelter pets and will be given to future adopters to make sure their pets will be protected from fleas throughout the summer season.

Rappaport joined the ParaDefense campaign to raise awareness of the need for preventative healthcare for all pets and to encourage pet lovers across the country to support disadvantaged, just rescued pets. “Trusted flea protection, which is crucial for our pets, is now available as a low-cost alternative at shelters and veterinary clinics. I take great comfort in knowing that all the shelter dogs and cats will now have the opportunity to be protected thanks to ParaDefense” says Rappaport.

ParaDefense has the proven ingredient Imidacloprid and the insect growth regulator Pyriproxyfen; the same active ingredients in the same concentration as found in well-known flea control. This once-a-month, topical flea prevention and treatment comes in a convenient, fragrance-free formulation. The difference in the new product is the price, not the benefits:
• Kills all flea life stages
• Starts working through contact
• Kills fleas that may cause flea allergy dermatitis
• Stops existing flea infestations and prevents reinfestation
• Kills fleas on dogs within 12 hours of initial application
• Remains effective even after bathing

ParaDefense is available in two sizes for cats and four sizes for dogs exclusively through your licensed veterinarian or shelter. Please visit ParaDefensePet.com for more information.

For more information about Southampton Animal Shelter Foundation, please visit SouthamptonAnimalShelter.com.

About CAP IM Supply, Inc.
ParaDefense is an EPA registered flea medication distributed by CAP IM Supply, Inc., a wholly owned subsidiary of CapInnoVet. CAP IM Supply, Inc. is a company dedicated to helping pets live healthier, happier lives by providing better access to high quality, low cost companion animal medications. ParaDefense is EPA registered and made in the USA.

*ParaDefenseTM is not manufactured by or distributed by Bayer. Advantage® II is a registered trademark of Bayer Healthcare LLC.
# # #

Leslie Oliver, CapInnoVet, http://paradefensepet.com, +1 479-899-3724, [email protected]

Modal title

Jill Rappaport at the Southampton Animal Shelter with a shelter volunteer at the ParaDefense shelter event.
Jill Rappaport at the Southampton Animal Shelter with a shelter volunteer at the ParaDefense shelter event.
Jill Rappaport and her four rescue dogs partner with ParaDefense on a national awareness campaign
Jill Rappaport and her four rescue dogs partner with ParaDefense on a national awareness campaign
Jill Rappaport and her rescue dog Ruby.
Jill Rappaport and her rescue dog Ruby.
Jill Rappaport with her dog Petey. Photograph by Christopher Appoldt.
Jill Rappaport with her dog Petey. Photograph by Christopher Appoldt.
Jill Rappaport at the Southampton Animal Shelter with a shelter volunteer at the ParaDefense shelter event. Jill Rappaport and her four rescue dogs partner with ParaDefense on a national awareness campaign Jill Rappaport and her rescue dog Ruby. Jill Rappaport with her dog Petey. Photograph by Christopher Appoldt.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.